Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Haleon Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (158)
ARTG (154)

Date

2025 (29)
2024 (9)
2023 (53)
2022 (34)
2021 (80)
2020 (13)
2019 (9)
2018 (2)
2017 (7)
2016 (3)
2015 (1)
2014 (2)
2013 (6)
2012 (6)
2011 (2)
2010 (11)
2009 (6)
2008 (5)
2007 (2)
2005 (1)
2004 (2)
2003 (2)
2002 (2)
2001 (4)
2000 (4)
1998 (1)
1997 (1)
1994 (1)
1993 (1)
1992 (4)
1991 (9)

Search

Sponsor content

312 result(s) found, displaying 11 to 20

PANADOL CHILDREN 5 - 12 years paracetamol 48 mg/mL oral suspension bottle (Tutti Frutti - Colourfree)(Reformulation) (489589)

22 May 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANADOL CHILDREN 5 - 12 years paracetamol 48 mg/mL oral suspension bottle (Tutti Frutti - Colourfree)(Reformulation).
PANADOL CHILDREN 5 - 12 years paracetamol 48 mg/mL oral suspension bottle (Orange - Colourfree)(Reformulation) (489588)

22 May 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANADOL CHILDREN 5 - 12 years paracetamol 48 mg/mL oral suspension bottle (Orange - Colourfree)(Reformulation).
PANADOL CHILDREN 1 - 5 years paracetamol 24 mg/mL oral suspension bottle (Orange - Colourfree)(Reformulation) (489564)

22 May 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANADOL CHILDREN 1 - 5 years paracetamol 24 mg/mL oral suspension bottle (Orange - Colourfree)(Reformulation).
Caltrate Joint Triple Benefits (486665)

24 April 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Caltrate Joint Triple Benefits.
CALTRATE 600 MG TABLETS Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
VoltaNatra Pain Relief Cream Heating Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
Centrum CALM & COLLECTED Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
Caltrate 600 mg Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
Haleon Australia Pty Ltd - Nasal irrigation saline solution, non-sterile Cancelled under Section 41GL(d) of the Act

27 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
Centrum Advance 50+ Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.